Interpace Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OID
Interpace Biosciences, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for August 20, 2026, to be held virtually.
OID
Interpace Biosciences, Inc. has filed a definitive proxy statement with the SEC.
OID
Interpace Biosciences will hold its annual stockholders meeting virtually on November 12, 2024, to vote on the ratification of its independent accounting firm and other business matters.